Author

N. Winssinger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:cell signaling & trafficking· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 1 Assay:imaging· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1 Organism:yeast· 1

Frequent Co-Authors

M. Dockerill· 2 shared S. Angerani· 2 shared C. Aumeier· 1 shared C. K. E. Bleck· 1 shared D. J. Ford· 1 shared D. Martinez Bedoya· 1 shared D. Migliorini· 1 shared E. Lindberg· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. Dockerill

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

PTPRZ1-targeting RNA CAR-T cells exert antigen-specific and bystander antitumor activity in glioblastoma

D. Martinez Bedoya, E. Marinari, S. Davanture, L. Castillo Cantero, S. Erraiss, M. Dockerill, S. Barluenga Badiola, N. Winssinger, K. Schaller, P. Bijlenga, S. Momjian, P. Hammel, P. Cosson, P. R. Walker, V. Dutoit, D. Migliorini

This study develops and validates anti-PTPRZ1 RNA CAR-T cells for glioblastoma treatment, showing antigen-specific and bystander antitumor activity in preclinical models.

bioRxiv · Dec 23, 2023Immunology

Development of supramolecular anticoagulants with on-demand reversibility

M. Dockerill, D. J. Ford, S. Angerani, I. Alwis, J. Ripoll-Rozada, R. E. Smythe, J. S. T. Liu, P. J. Barbosa Pereira, S. P. Jackson, R. J. Payne, N. Winssinger

This paper develops supramolecular anticoagulants that can be reversed on demand using a PNA antidote, demonstrating potent in vitro and in vivo anticoagulant activity.

bioRxiv · Nov 12, 2023Biochemistry

Kinesin-1 motility traced by an activity-based precipitating dye

S. Angerani, E. Lindberg, N. Klena, C. K. E. Bleck, C. Aumeier, N. Winssinger

This study develops a fluorogenic substrate that visualizes kinesin-1 motility in live cells by producing a precipitating dye along its transport path.

bioRxiv · Aug 12, 2020 · PreprintBiochemistry

Chemical genetics of AGC-kinases reveals shared targets of Ypk1, Protein Kinase A and Sch9

M. Plank, M. Perepelkina, M. Müller, S. Vaga, X. Zou, M. Berti, J. Saarbach, S. Haesendonckx, N. Winssinger, R. Aebersold, R. Loewith

The paper identifies shared targets of Ypk1, PKA, and Sch9 by comparing phospho-proteomes under chemical inhibition, revealing Ypk1's role in phosphorylating and activating Nth1.

bioRxiv · Sep 4, 2019Cell Biology